全文获取类型
收费全文 | 5068篇 |
免费 | 329篇 |
国内免费 | 256篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 32篇 |
妇产科学 | 56篇 |
基础医学 | 366篇 |
口腔科学 | 22篇 |
临床医学 | 301篇 |
内科学 | 582篇 |
皮肤病学 | 51篇 |
神经病学 | 189篇 |
特种医学 | 45篇 |
外科学 | 172篇 |
综合类 | 356篇 |
预防医学 | 180篇 |
眼科学 | 17篇 |
药学 | 2677篇 |
中国医学 | 321篇 |
肿瘤学 | 280篇 |
出版年
2024年 | 8篇 |
2023年 | 33篇 |
2022年 | 57篇 |
2021年 | 91篇 |
2020年 | 93篇 |
2019年 | 146篇 |
2018年 | 164篇 |
2017年 | 152篇 |
2016年 | 155篇 |
2015年 | 145篇 |
2014年 | 257篇 |
2013年 | 459篇 |
2012年 | 289篇 |
2011年 | 280篇 |
2010年 | 275篇 |
2009年 | 248篇 |
2008年 | 271篇 |
2007年 | 267篇 |
2006年 | 225篇 |
2005年 | 201篇 |
2004年 | 213篇 |
2003年 | 201篇 |
2002年 | 130篇 |
2001年 | 109篇 |
2000年 | 123篇 |
1999年 | 113篇 |
1998年 | 83篇 |
1997年 | 85篇 |
1996年 | 93篇 |
1995年 | 68篇 |
1994年 | 49篇 |
1993年 | 36篇 |
1992年 | 52篇 |
1991年 | 48篇 |
1990年 | 33篇 |
1989年 | 41篇 |
1988年 | 32篇 |
1987年 | 34篇 |
1986年 | 18篇 |
1985年 | 45篇 |
1984年 | 45篇 |
1983年 | 15篇 |
1982年 | 24篇 |
1981年 | 21篇 |
1980年 | 14篇 |
1978年 | 17篇 |
1977年 | 20篇 |
1976年 | 21篇 |
1975年 | 10篇 |
1974年 | 21篇 |
排序方式: 共有5653条查询结果,搜索用时 15 毫秒
41.
42.
Mepyramine对肝脏疾病肝微粒体膜流动性的影响 总被引:1,自引:0,他引:1
目的:探讨Mepyramine对肝脏疾病肝微粒体膜流动性的影响.方法:以1,6-diphenyl-1,3,5-hexatriene(DPH)作为荧光探剂,应用荧光偏振技术研究大鼠急性肝炎、大鼠肝硬化肝微粒体膜流动性(LMMF)的变化,并在体外实验观察mepyramine(MPR)对LMMF的影响.结果:①LMMF在大鼠发生急性肝炎时升高,与对照组相比有显著性差异(P<0.o1),而大鼠发生肝硬化时降低,与对照组相比有显著性差异(P<0.05).②10-4mol/L MPR可使正常大鼠、大鼠肝硬化及人体肝癌组织LMMF升高(P分别小于0.01,0.01,0.05).结论:肝病时LMMF出现异常;MPR可以升高LMMF,其机制可能与阻断抗组胺药敏感性细胞色素P450(HP-450)有关. 相似文献
43.
The number of published reports associating hepatotoxicity with paracetamol ingestion at therapeutic or near-therapeutic dose levels is small but is, nevertheless, suggestive of a relationship. There is however, mounting evidence that certain groups of patients, such as alcohol-dependent people, patients receiving enzyme-inducing drugs (particularly anti-convulsant and anti-tuberculosis medications) as well as those with certain infectious diseases, are rendered more susceptible to paracetamol-induced hepatotoxicity. Seventy-four case reports where therapeutic or near-therapeutic doses of paracetamol resulted in hepatic injury are reviewed and factors and mechanisms which might explain this apparently increased vulnerability to damage are discussed. 相似文献
44.
T. Kokufu N. Ihara N. Sugioka H. Koyama T. Ohta S. Mori K. Nakajima 《European journal of clinical pharmacology》1995,48(5):391-395
The effect of the new substituted benzimidazole proton pump inhibitor, lansoprazole, on pharmacokinetics and metabolism of theophylline has been studied in healthy adults given oral lansoprazole 30 mg once daily for 11 days. On Days 4 and 11 of 300 mg aminophylline was simultaneously administered orally and blood samples for theophylline analysis were taken over 24 h. Urine samples were collected for up to 24 h and were assayed for theophylline and its major metabolites 1,3-dimethyluric acid (1,3-DMU), 1-methyluric acid (1-MU) and 3-methylxanthine (3-MX). The pharmacokinetic parameters of theophylline were determined, and the urinary recovery of unchanged theophylline and its major metabolites were calculated.After administration of lansoprazole for 4 days, no significant alteration in the terminal elimination half-life (t
1/2) or the mean residence time (MRT) was detected. However, there was a significant decrease of about 13% in the area under the plasma concentration-time curve (AUC) and a significant increase of about 19% in the apparent clearance (CLapp). Lansoprazole treatment for 11 days caused a significant decrease of approximately 12% in t
1/2 and about 10% in the MRT of theophylline, although neither AUC nor CLapp showed a significant alteration. The excretion of 3-MX in the urine was significantly increased by about 20% after lansoprazole treatment for 4 and 11 days, although there was no significant alteration in the excretion of unchanged theophylline, 1,3-DMU or 1-MU.The results indicate that repeated administration of lansoprazole to humans induces the hepatic microsomal P-450-dependent drug oxidation system that mediates N-1-demethylation of theophylline, consequently increasing its metabolism. 相似文献
45.
The cytochrome P450 isoenzymes are a superfamily of haemoprotein enzymes that catalyse the metabolism of a large number of endogenous and exogenous compounds. Recently, the cytochrome isoenzymes have been shown to be important in the synthesis of steroid hormones and bile acids, the arachidonic acid cascade and in central nervous function. These enzymes are a major determinant of the pharmacokinetic behaviour of numerous drugs. Furthermore, alterations in cytochrome P450 activity have been implicated in some diseases. 相似文献
46.
Kortunay S Bozkurt A Bathum L Basci NE Calgüneri M Brøsen K Kayaalp SO 《European journal of clinical pharmacology》1999,55(1):21-25
Objectives: To determine whether patients with idiopathic systemic lupus erythematosus (SLE) are associated with impaired CYP2D6 activity
and to gain insight into whether there is an association between particular CYP2D6 genotypes and susceptibility to SLE, and whether CYP2D6 polymorphism is linked to any specific clinical features of SLE.
Methods: Debrisoquine sulfate (10 mg p.o.) was given to 159 healthy volunteers and 39 idiopathic SLE patients. Genotypic assay was
carried out in 80 healthy volunteers and 32 patients. A 10-ml blood sample was drawn for genotypic assay. Debrisoquine and
4-hydroxydebrisoquine were determined in 8-h urine samples. Blood samples were analysed for the presence of mutations in the
CYP2D6 gene, by using polymerase chain reaction (PCR) specific for CYP2D6*3 and CYP2D6*4 alleles.
Results: The metabolic ratio of debrisoquine to 4-hydroxydebrisoquine ranged from 0.01 to 86.98 in healthy subjects and from 0.02
to 96 in SLE patients. We observed the poor metabolizer(PM) debrisoquine phenotype in three of 39 patients with idiopathic
SLE (7.6%) and five of 159 healthy subjects (3.1%). There was no significant difference in the frequency of PM phenotypes
between idiopathic SLE and healthy subjects (Fisher's exact test, P = 0.19). No significant difference in the distribution of overall genotypes and allele frequencies were observed between
the two groups. No significant relationships were found between specific clinical features and the overall genotype.
Conclusion: The results of this study confirm that CYP2D6 activity is not impaired in SLE and that there is no association between SLE
and phenotypic CYP2D6 status. The results also showed that there was no difference in the frequency of CYP2D6A and CYP2D6B alleles between controls and patients with SLE.
Received: 14 May 1998 / Accepted in revised form: 19 October 1998 相似文献
47.
Amphetamine stimulates locomotor activity, in large part by activating central dopaminergic systems. Serotonin shares on
overlapping distribution with dopamine and has been shown to modulate dopaminergic function and dopamine-mediated behaviors.
The present study examined whether increasing serotonergic function, via the selective serotonin reuptake inhibitor fluoxetine,
would alter the stimulatory effects of amphetamine on locomotor activity and dopamine overflow in the nucleus accumbens. In
addition, the present study determined whether fluoxetine treatment would alter the metabolism of amphetamine. Results show
that 5.0 mg/kg fluoxetine potentiated the locomotor activity induced by amphetamine (0.5–1.0 mg/ kg), and enhanced the increased
dopamine overflow in the nucleus accumbens induced by amphetamine. Fluoxetine treatment also resulted in a higher concentration
of amphetamine in the CNS. Together, these findings indicate that acute fluoxetine treatment potentiates the locomotor stimulating
and dopamine activating effects of amphetamine. Further, the results indicate that fluoxetine potentiates the effects of amphetamine
by decreasing the metabolism of amphetamine, probably through inhibition of cytochrome P450 isozymes.
Received: 5 May 1998/Final version: 7 July 1998 相似文献
48.
49.
Effects of Diethyl Phthalate and Other Plasticizers on Laurate Hydroxylation in Rat Liver Microsomes
Diethyl phthalate (DEP) is used in pharmaceutical coatings, cosmetics, and plastic films to wrap foods. There is a health concern associated with the exposure to certain phthalate esters because they belong to a class of compounds referred to as peroxisome proliferators which have been shown to increase the incidence of liver tumors when administered to rats. In this study, we have compared DEP to four other commonly used plasticizers, 2-diethylhexyl phthalate (DEHP), dibutyl phthalate (DBP), 2-diethylhexyl adipate (DEHA), and acetyltributyl citrate (ATBC), for their ability to induce the cytochrome P450-mediated fatty acid -hydroxylation system, which is one of the initial cellular responses when animals are treated with peroxisome proliferators. The administration of DEHP, DBP, and DEHA to rats increased the specific activity of laurate 12-hydroxylase from 2.8 ± 1.1 in control rats to 30.3 ± 11.6, 14.5 ± 4.1, and 9.7 ± 1.9 nmol 12-hydroxylaurate formed/min/nmol P450, respectively. In contrast, laurate 12-hydroxylase activity in DEP-and ATBC-treated rats were 4.4 ± 1.2 and 4.4 ± 1.0 nmol 12-hydroxylaurate formed/min/nmol P450, respectively. In addition, whereas DEHP increased peroxisomal palmitoyl-CoA oxidation 6-fold, DEP increased this activity only 1.3-fold. Two protein bands, at 51 and 52 kDa, were found to increase 6- to 12-fold in microsomes of DEHP-, DBP-, and DEHA-treated rats, but these bands were increased only 2-fold in DEP- or ATBC-treated rats. 相似文献
50.
V. Rogiers A. Callaerts A. Vercruysse M. Akrawi E. Shephard I. Phillips 《Pharmacy World & Science》1992,14(3):127-131
Male Wistar rats werein vivo exposed for 2 weeks to 100 g/ml sodium valproate by subcutaneous implantation of osmotic pumps and hepatocytes were isolated. As anin vitro model co-cultures of rat hepatocytes with epithelial cells were daily treated with valproate (25, 50, 100, 200g/ml) for 2 weeks. In both models the cytochrome P-450 content and the enzymatic activities of 7-ethoxycoumarinO-deethylase, aldrin epoxidase and glutathioneS-transferase were determined in valproate-treated hepatocytes, in controls and in phenobarbital-induced cells. It appeared that in both systems the cytochrome P-450 content and the 7-ethoxycoumarinO-deethylase activity increased significantly after valproate treatment. On the other hand, the activities of aldrin epoxidase and glutathioneS-transferase decreased. A cDNA probe, encoding rat P450IIB2 was used to determine whether mRNAs encoding the P450IIB subfamily were induced by valproate. It became clear that the inducing effect of valproate was even more pronouncedin vitro thanin vivo. 相似文献